GWM Advisors LLC

SEC CIK: 0001633516
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by GWM Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overview All 13F holders of LCTX Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2022

Holdings of LCTX by GWM Advisors LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−11,500−100.0%	Sold out	Holders
Q3 2025	11,500	$19.4K	<0.1%	+11,500	New	Holders
Q2 2023	0	$0	0.0%	−12−100.0%	Sold out	Holders
Q1 2023	12	$18	<0.1%	00.0%	Unchanged	Holders
Q4 2022	12	$0	0.0%	+12	New	Holders